Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propiverine ER tolerability in male patients with LUTS and BPH/BPS
2004-000871-33Phase 3Completed
- Sponsor
- APOGEPHA
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of propiverine in benign prostatic hyperplasia (BPH) and Micturition disorder, sponsored by APOGEPHA. Primary endpoint: Residual urine. Started Oct 2004; status: completed.
02
Drugs
propiverine
03
Conditions
benign prostatic hyperplasia (BPH)Micturition disorder
Beyond the preview
Go deeper on 2004-000871-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000871-33.